NRF2 and p53: Januses in cancer?
- PMID: 23174755
- PMCID: PMC3717791
- DOI: 10.18632/oncotarget.754
NRF2 and p53: Januses in cancer?
Abstract
The transcription factor nuclear factor (erythroid-derived 2)-like 2, also known as NFE2L2 or NRF2, is a master regulator of the anti-oxidative stress response and positively controls the expression of a battery of anti-oxidative stress response proteins and enzymes implicated in detoxification and glutathione generation. Although its detoxifying activity is important in cancer prevention, it has recently been shown that cancer cells also exploit its protective functions to thrive and resist chemotherapy. NRF2 was also shown to the pentose phosphate pathway and glutaminolysis, which promotes purine synthesis for supporting rapid proliferation and glutathione for providing anti-oxidative stress protection. Evidence obtained from cancer patients and cell lines suggest that NRF2 is highly active in a variety of human cancers and is associated with aggressiveness. p53 is a tumor suppressor that also promotes an anti-oxidative stress metabolic program and glutaminolysis. Here we will discuss the similarities between NRF2 and p53 and review evidence that p53 might be exploited by cancer cells to gain protection against oxidative stress, as is the case for NRF2. We discuss findings of co-regulation between these transcription factors and propose possible therapeutic strategies that can be used for treatment of cancers that harbor WT p53 and express high levels of NRF2.
Figures
Similar articles
-
The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer.Biochem Med (Zagreb). 2023 Oct 15;33(3):030504. doi: 10.11613/BM.2023.030504. Biochem Med (Zagreb). 2023. PMID: 37841775 Free PMC article. Review.
-
MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.Biochim Biophys Acta Mol Cell Res. 2018 Aug;1865(8):1034-1045. doi: 10.1016/j.bbamcr.2018.04.011. Epub 2018 Apr 26. Biochim Biophys Acta Mol Cell Res. 2018. PMID: 29704532
-
The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.J Biol Chem. 2020 Mar 6;295(10):3055-3063. doi: 10.1074/jbc.RA119.011930. Epub 2020 Jan 30. J Biol Chem. 2020. PMID: 32001619 Free PMC article.
-
Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.Free Radic Biol Med. 2014 Sep;74:21-34. doi: 10.1016/j.freeradbiomed.2014.06.010. Epub 2014 Jun 24. Free Radic Biol Med. 2014. PMID: 24970682
-
Oxidative Stress and Cancer: The Role of Nrf2.Curr Cancer Drug Targets. 2018;18(6):538-557. doi: 10.2174/1568009617666171002144228. Curr Cancer Drug Targets. 2018. PMID: 28969555 Review.
Cited by
-
Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia.Cancers (Basel). 2022 Oct 6;14(19):4881. doi: 10.3390/cancers14194881. Cancers (Basel). 2022. PMID: 36230804 Free PMC article. Review.
-
On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer.Oncotarget. 2016 Oct 11;7(41):67626-67649. doi: 10.18632/oncotarget.11759. Oncotarget. 2016. PMID: 27590516 Free PMC article. Review.
-
Glucose negatively affects Nrf2/SKN-1-mediated innate immunity in C. elegans.Aging (Albany NY). 2018 Nov 15;10(11):3089-3103. doi: 10.18632/aging.101610. Aging (Albany NY). 2018. PMID: 30442878 Free PMC article.
-
Cytoprotection "gone astray": Nrf2 and its role in cancer.Onco Targets Ther. 2014 Aug 26;7:1497-518. doi: 10.2147/OTT.S36624. eCollection 2014. Onco Targets Ther. 2014. PMID: 25210464 Free PMC article. Review.
-
Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis.PLoS One. 2020 Nov 13;15(11):e0241241. doi: 10.1371/journal.pone.0241241. eCollection 2020. PLoS One. 2020. PMID: 33186371 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous